JPRN-C000000439
Unknown
Phase 1
Phase 1/2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancer - Phase1/2 study of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancer
Department of Respiratory Medicine of Kyoto University Hospital0 sites32 target enrollmentJuly 1, 2006
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Preaviously untreated advanced advanced squamous cell lung cancer
- Sponsor
- Department of Respiratory Medicine of Kyoto University Hospital
- Enrollment
- 32
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Interstitial pneumonia or pulmonary fibrosis on chest X\-P 2\) peural or pericardial effusion requiring drainage 3\) SVC syndrome 4\) Symptomatic brain metastases 5\) Active concominant malignancies 6\) Uncontrolled diabetes mellitus or hypertension 7\) Liver cirrhosis 8\) Severe cardiovascular diseases 9\) Pregnancy and lactation 10\) Ccr\<60ml/min 11\) A history of serious drug allergy 12\) Acute infection 13\) Bleeding tendency 14\) Unsuitable for entry to the study, decided by a medical oncologist
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Phase 2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerung squamous cell carcinomaJPRN-UMIN000004833First Department of Surgery, Hamamatsu University School of Medicine25
Completed
Not Applicable
A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancerpreviously untreated elderly non-small cell lung cancerJPRN-C000000072West Japan Oncology Group25
Completed
Phase 2
Phase II trial of the combination of gemcitabine and 131I-MIBG therapy in paediatric patients with relapsed or progressive neuroblastomaNL-OMON39557Academisch Medisch Centrum16
Active, not recruiting
Not Applicable
A phase II study of the combination of gemcitabine with 131I-MIBG therapy for children with neuroblastoma without other treatment options.relapsed or progressive neuroblastoma in pediatric patients of 1 to 18 yearsTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2007-007974-45-NLAMC47
Completed
Phase 2
A combination phase II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancer.on-small cell lung cancerJPRN-C000000135Institute of Biomedical Research and Innovation40